Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP595340.RA78Kl3slTgxaGiYwVEydQRaBcN11Tc0sy6HS-1ZYvjE4130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595340.RA78Kl3slTgxaGiYwVEydQRaBcN11Tc0sy6HS-1ZYvjE4130_provenance.
• NP58922.RAVdgYS4yDet8eBu7qwjEAy_QEP0KcElUBUplO9r2gizk130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP58922.RAVdgYS4yDet8eBu7qwjEAy_QEP0KcElUBUplO9r2gizk130_provenance.
• NP133776.RAVLUITJ0h-oyhY3JuAbGvio76CzpE2pjuYKqftXZ2uLQ130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133776.RAVLUITJ0h-oyhY3JuAbGvio76CzpE2pjuYKqftXZ2uLQ130_provenance.
• NP133787.RAV0X9ePhe6x4KbL2f7IQPX4uHfWxa-uTg-4C6SYGdKio130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133787.RAV0X9ePhe6x4KbL2f7IQPX4uHfWxa-uTg-4C6SYGdKio130_provenance.
• NP134437.RAXmZW6CnCbuPYutd1NV_2Z__PjKxMcsezp35KlCAhZEM130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134437.RAXmZW6CnCbuPYutd1NV_2Z__PjKxMcsezp35KlCAhZEM130_provenance.
• NP69600.RAfADhVkIeWN5BmQmagwCkPlE9I4KYPtHNoxNtLG0pR04130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP69600.RAfADhVkIeWN5BmQmagwCkPlE9I4KYPtHNoxNtLG0pR04130_provenance.
• NP539569.RATlmuLF5RUwuJ--9cmiBKH_MRQYFoJpWYITnAoPjkO7E130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539569.RATlmuLF5RUwuJ--9cmiBKH_MRQYFoJpWYITnAoPjkO7E130_provenance.
• NP98423.RAmA6eiL0LZuRrkxICRzfVbDZtn7kLw0k3r9D_PBTBcxE130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP98423.RAmA6eiL0LZuRrkxICRzfVbDZtn7kLw0k3r9D_PBTBcxE130_provenance.
• NP134733.RAs0hy7wDa1Yd1SFUQvkQ2NyIURy6WJkN3HriPmHJUYaQ130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134733.RAs0hy7wDa1Yd1SFUQvkQ2NyIURy6WJkN3HriPmHJUYaQ130_provenance.
• NP134914.RAunKJZhXZ63F_9BRd0MumufRyQc6NyzDPFTceJH74MUo130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134914.RAunKJZhXZ63F_9BRd0MumufRyQc6NyzDPFTceJH74MUo130_provenance.
• NP58554.RAnWhYKg_qV30IGcenCSALRQ9P45MSTXmYNbJwkxL6dqo130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP58554.RAnWhYKg_qV30IGcenCSALRQ9P45MSTXmYNbJwkxL6dqo130_provenance.
• NP58564.RAtaX3uLWT76Jcbpo-eq9xRXh53hbWBvv76e3PAfA0b2E130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP58564.RAtaX3uLWT76Jcbpo-eq9xRXh53hbWBvv76e3PAfA0b2E130_provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP111663.RAfuMsa-Vp0dbparqQiyCo18VaWTUdrl3VOHv2yUf9hMk130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111663.RAfuMsa-Vp0dbparqQiyCo18VaWTUdrl3VOHv2yUf9hMk130_provenance.
• NP111669.RAa6IfVAWmUjNuHlrULX-x00vpybEK9DMmTu3EHdTDL84130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111669.RAa6IfVAWmUjNuHlrULX-x00vpybEK9DMmTu3EHdTDL84130_provenance.
• NP111670.RAaFdJdcXZIk_pvFEjGMCRCTbvLhrZmbWYcSdv3jerutM130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111670.RAaFdJdcXZIk_pvFEjGMCRCTbvLhrZmbWYcSdv3jerutM130_provenance.
• NP111672.RAbJgLhTWvdtvt0cIlnOyvw209TWaztfC1-rO1SiXeQ1Y130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111672.RAbJgLhTWvdtvt0cIlnOyvw209TWaztfC1-rO1SiXeQ1Y130_provenance.
• NP94166.RAs3PpD0gOXqdZxRYLX7SDCzgHmPnWVbO3ZLaOxCIc7vk130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94166.RAs3PpD0gOXqdZxRYLX7SDCzgHmPnWVbO3ZLaOxCIc7vk130_provenance.
• NP111660.RABkD3br3JptQsJmi34yT4QsfSk-a_3IILb6LVknINOxg130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111660.RABkD3br3JptQsJmi34yT4QsfSk-a_3IILb6LVknINOxg130_provenance.
• NP246474.RAm3FA4TMV9qKXQBObJnizhruRm7zs-vY_hL7dwzlFJgU130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246474.RAm3FA4TMV9qKXQBObJnizhruRm7zs-vY_hL7dwzlFJgU130_provenance.
• NP69534.RA3jAxBuH9XAmCSlfA330js7vU-RLUXhd5_ehl1lkC4Ek130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP69534.RA3jAxBuH9XAmCSlfA330js7vU-RLUXhd5_ehl1lkC4Ek130_provenance.
• NP111652.RAuci2-JhqLP37332OXzmBBgSMND-ghYYt4l7Pbqx86Rk130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111652.RAuci2-JhqLP37332OXzmBBgSMND-ghYYt4l7Pbqx86Rk130_provenance.
• NP111656.RAk1e_Pi5UwbP3e5HQV3Gy79YQby8bJBzdbfzc5oL-ofM130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111656.RAk1e_Pi5UwbP3e5HQV3Gy79YQby8bJBzdbfzc5oL-ofM130_provenance.
• NP58879.RAGywnysu0MbOKabSPDdw3NFebuZc6C3aO3pd7pVvjZTA130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP58879.RAGywnysu0MbOKabSPDdw3NFebuZc6C3aO3pd7pVvjZTA130_provenance.
• NP94172.RAOKrSbw8e9rJSlwJbM23-VcBo5p7io5d_dFiKsQ1PVOA130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94172.RAOKrSbw8e9rJSlwJbM23-VcBo5p7io5d_dFiKsQ1PVOA130_provenance.
• NP69610.RAIDcn_978pufh4oPGBnCPEKA7D0aOg-EahWfPjJdtUuE130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP69610.RAIDcn_978pufh4oPGBnCPEKA7D0aOg-EahWfPjJdtUuE130_provenance.
• NP629522.RAmuNuC5jxMZE4wlvq2zPymLQekBiNnFLe9mUfxK-jAZM130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629522.RAmuNuC5jxMZE4wlvq2zPymLQekBiNnFLe9mUfxK-jAZM130_provenance.
• NP133791.RA2w04UP5bN7y6Dyjntb6LUQRzKU0x0t6jp3Tg8SGTNPY130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133791.RA2w04UP5bN7y6Dyjntb6LUQRzKU0x0t6jp3Tg8SGTNPY130_provenance.
• NP134847.RAGcXRzonMeOjk8n70Jy_2tUZ7vEcvUF5cJKIPRa_B8a0130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134847.RAGcXRzonMeOjk8n70Jy_2tUZ7vEcvUF5cJKIPRa_B8a0130_provenance.
• NP111658.RAM7AoyUygIgBK8MnKtT1MX5LVJknE9LDt9OZJkbDpaJs130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111658.RAM7AoyUygIgBK8MnKtT1MX5LVJknE9LDt9OZJkbDpaJs130_provenance.
• NP111659.RAE3ikNCcs6UmMW-IzWNqjqHm2ozuLAnsLODv3EnT8u0g130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111659.RAE3ikNCcs6UmMW-IzWNqjqHm2ozuLAnsLODv3EnT8u0g130_provenance.
• NP111662.RAJRPaFvFtXlsBWUBYgkiRYGaoUIdslYMuF_Tyg5tCvXo130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111662.RAJRPaFvFtXlsBWUBYgkiRYGaoUIdslYMuF_Tyg5tCvXo130_provenance.
• NP111666.RAF_gS23Ig2xsV7u-eb8xuuDOSyUKScVkRIissLEhN8Ls130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111666.RAF_gS23Ig2xsV7u-eb8xuuDOSyUKScVkRIissLEhN8Ls130_provenance.
• NP111667.RALFYmSunHiT9-QUeE_vEZ0-QU0nZMZD1mjGl8Jnc5Fc4130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111667.RALFYmSunHiT9-QUeE_vEZ0-QU0nZMZD1mjGl8Jnc5Fc4130_provenance.
• NP111668.RAP1WdJkLocAYNWo1l3fKFQN7JktPPrQbBmWbTDBGsnqE130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111668.RAP1WdJkLocAYNWo1l3fKFQN7JktPPrQbBmWbTDBGsnqE130_provenance.
• NP629520.RAzQOw8BswLOqcauisFYU5_3peCOhcoyQz-cm-QgRQPRI130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629520.RAzQOw8BswLOqcauisFYU5_3peCOhcoyQz-cm-QgRQPRI130_provenance.
• NP111653.RAy3OM6OJPlWzYf6E8JKefTYwXnsk-TZ5AhDAOnZ-PpVQ130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111653.RAy3OM6OJPlWzYf6E8JKefTYwXnsk-TZ5AhDAOnZ-PpVQ130_provenance.
• NP111654.RA--R5RMK9l-eRzxgA_1-KeAis3MggXMiGsuCNpWUxt6g130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111654.RA--R5RMK9l-eRzxgA_1-KeAis3MggXMiGsuCNpWUxt6g130_provenance.
• NP111655.RA5rdfcay102sSGmSUJzGKw32eeHj0tgr0Y74XpPR1xjk130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111655.RA5rdfcay102sSGmSUJzGKw32eeHj0tgr0Y74XpPR1xjk130_provenance.
• NP111657.RAz-4r8q77rDRKIx8OZ-jOM3CjZImkHQL-eSprfyjv-6Q130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111657.RAz-4r8q77rDRKIx8OZ-jOM3CjZImkHQL-eSprfyjv-6Q130_provenance.
• NP111661.RA8YXeZVY6Hi-XRJJjn45V3maTFQVNSnQ6UvoenyRFMcM130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111661.RA8YXeZVY6Hi-XRJJjn45V3maTFQVNSnQ6UvoenyRFMcM130_provenance.
• NP111664.RA0DYFZKd4iyALPr97rhlv-NlPuvPiXoxKjtOJVlVdZa4130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111664.RA0DYFZKd4iyALPr97rhlv-NlPuvPiXoxKjtOJVlVdZa4130_provenance.
• NP111665.RAyp9VS2qVUYLbcj4X5_A9i5EdtTekmosyTl2NK-_vEwk130_assertion description "[Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111665.RAyp9VS2qVUYLbcj4X5_A9i5EdtTekmosyTl2NK-_vEwk130_provenance.